Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Takahiro Yoshio"'
Autor:
Hisao Kuroda, Motoo Utsumi, Takahiro Yoshio, Hideshige Toda, Tatsumi Kitamura, Keiji Watanabe
Publikováno v:
Journal of Japan Society on Water Environment. 41:213-221
Autor:
Yang Zhao, Rujie Liu, Wenqian Xue, Ming Yang, Masahiro Shiraishi, Shuji Awai, Yu Maruyama, Takahiro Yoshioka, Takeshi Konno
Publikováno v:
IEEE Access, Vol 11, Pp 102623-102634 (2023)
Silhouette and pose are two common features to extract the descriptive and unique patterns of a person’s gait, and good performance has been already achieved driven by the deep learning techniques. However, some issues still exist, the silhouette i
Externí odkaz:
https://doaj.org/article/7c37800e56d1442b9c6b193da408861d
Autor:
Hideshige Toda, Kouya Nakamura, Yuji Hanamachi, Keiji Watanabe, Toshiomi Ida, Tatsumi Kitamura, Hisao Kuroda, Seiji Hayashi, Takahiro Yoshio, Noriyuki Sunou
Publikováno v:
Journal of Japan Society on Water Environment. 37:265-271
Autor:
Takahiro Yoshio, Nobuyuki Komatsu, Toshio Tabuchi, Hisao Kuroda, Tatsumi Kitamura, Yuichi Ishii, Keiji Watanabe, Mamiko Yamamoto, Takamitsu Homma
Publikováno v:
Journal of Japan Society on Water Environment. 34:73-80
Autor:
Kei Namba, Shuta Tomida, Takehiro Matsubara, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Takahiro Yoshioka, Tatsuaki Takeda, Hidejiro Torigoe, Hiroki Sato, Kazuhiko Shien, Hiromasa Yamamoto, Junichi Soh, Kazunori Tsukuda, Shinichi Toyooka
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background In lung cancer, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor sensitizing mutations co-existing with rare minor EGFR mutations are known as compound mutations. These minor EGFR mutations can lead to acquired re
Externí odkaz:
https://doaj.org/article/0061557ff09a4c7f96518cb52de7af72
Publikováno v:
Surgical Case Reports, Vol 4, Iss 1, Pp 1-5 (2018)
Abstract Background The indications for negative pressure wound therapy (NPWT) continue to expand, and NPWT has become a powerful tool for the treatment of interactive wounds. Recently, the use of NPWT over closed incisions has been shown to prevent
Externí odkaz:
https://doaj.org/article/2ba8c52203c64683ab3a3fa623440854
Autor:
Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, Ken Suzawa, Takahiro Yoshioka, Shuta Tomida, Xiaojiang Cui, Ramachandran Murali, Kei Namba, Hiroki Sato, Hidejiro Torigoe, Mototsugu Watanabe, Kazuhiko Shien, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Yoshihisa Kitamura, Shinichiro Miyoshi, Toshiaki Sendo, Shinichi Toyooka
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171356 (2017)
Overexpression of human epidermal growth factor receptor 2 (HER2) is observed in approximately 15-23% of breast cancers and these cancers are classified as HER2-positive breast cancer. Trastuzumab is the first-line targeted therapeutic drug for HER2-
Externí odkaz:
https://doaj.org/article/5b2dfa564e694a529e34914eeba067c8